Literature DB >> 8731941

Correlative study on the expression of p53 and DNA ploidy in acute nonlymphocytic leukemia.

F R Lin1, E G Yao, L F Zuo, S R Xu, J H Ren, S Y Liu, J P Wei.   

Abstract

We used the flow cytometric immunoassay to study the correlation between the rumor-suppressor gene product p53- and the DNA ploidy in 30 de novo cases of acute nonlymphocytic leukemia (ANLL). The results showed that 15 cases were positive expression for p53. As compared with p53 negative (p53) cases, the patients with positive p53 (p53+) had higher percentage of bone marrow blasts and lower peripheral leukocyte and platelet counts, which had no influence on the complete remission rate. Before treatment, DNA diploidy was seen in 18 cases including 12 p53- cases, and DNA aneuploidy in 12 cases including 9 p53+. After therapy, aneuploidy could be transformed into diploidy. Patients with P53+ or having aneuploidy in complete remission were at risk for early relapse. We believe that p53 may be involved in the process of leukemogenesis and progression of ANLL.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8731941     DOI: 10.1007/BF02888222

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  8 in total

1.  Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.

Authors:  R X Zhang; E G Yao
Journal:  Chin Med J (Engl)       Date:  1990-10       Impact factor: 2.628

2.  Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia.

Authors:  M Danova; M Giordano; G Mazzini; A Riccardi
Journal:  Leuk Res       Date:  1990       Impact factor: 3.156

3.  The effect of chemotherapy on the in vivo frequency of glycophorin A 'null' variant erythrocytes.

Authors:  W L Bigbee; A J Wyrobek; R G Langlois; R H Jensen; R B Everson
Journal:  Mutat Res       Date:  1990-03       Impact factor: 2.433

Review 4.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

5.  Flow cytometry DNA measurement for prediction of effect of therapy in acute leukemia.

Authors:  R X Zhang; E G Yao
Journal:  J Tongji Med Univ       Date:  1990

Review 6.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

7.  Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus.

Authors:  R G Langlois; W L Bigbee; R H Jensen
Journal:  Hum Genet       Date:  1986-12       Impact factor: 4.132

8.  Expression of the p53 oncogene in acute myeloblastic leukemia.

Authors:  L J Smith; E A McCulloch; S Benchimol
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.